100 related articles for article (PubMed ID: 7965276)
1. Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension.
Ruilope LM; Lahera V; Alcázar JM; Praga M; Campo C; Rodicio JL
J Hypertens Suppl; 1994 Jul; 12(4):S59-63. PubMed ID: 7965276
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
3. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
Pascual JM; Rodilla E; Miralles A; Gonzalez C; Redon J
J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551
[TBL] [Abstract][Full Text] [Related]
4. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
5. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
6. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
7. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
9. Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria.
Ebbehøj E; Poulsen PL; Hansen KW; Knudsen ST; Mølgaard H; Mogensen CE
Diabetologia; 2002 Jul; 45(7):965-75. PubMed ID: 12136395
[TBL] [Abstract][Full Text] [Related]
10. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
13. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
15. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
[TBL] [Abstract][Full Text] [Related]
17. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
19. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
20. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension.
Ruilope LM; Alcázar JM; Hernández E; Praga M; Lahera V; Rodicio JL
Kidney Int Suppl; 1994 Feb; 45():S171-3. PubMed ID: 7908997
[No Abstract] [Full Text] [Related]
[Next] [New Search]